Pemoline in ADHD
Abstract
The effects of pemoline (Cylert) in 28 children with attention deficit disorder (ADD), 23 with and 5 without hyperactivity, were evaluated for dose-response, timing of response after ingestion, and duration of effect, in a double-blind, placebo-controlled, crossover study at the Child Development Clinic of the Department of Neurology, Hospital for Sick Children, Toronto, Canada.
DOI: https://doi.org/10.15844/pedneurbriefs-9-11-2 | Journal eISSN: 2166-6482
Language: English
Page range: 81 - 82
Published on: Nov 1, 1995
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
Keywords:
© 1995 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.